tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
PremiumThe FlyClosing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
2M ago
MacroGenics reports Q2 EPS (57c), consensus (38c)
Premium
The Fly
MacroGenics reports Q2 EPS (57c), consensus (38c)
2M ago
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors?
Premium
Company Announcements
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors?
2M ago
MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
PremiumCompany AnnouncementsMacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
2M ago
MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
Premium
Company Announcements
MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
2M ago
MacroGenics Advances Cancer Treatment with MGC026 Study Update
Premium
Company Announcements
MacroGenics Advances Cancer Treatment with MGC026 Study Update
3M ago
MacroGenics Inc. Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsMacroGenics Inc. Reports Q1 2025 Financial Results
5M ago
MacroGenics: Strategic Pipeline Shifts and Financial Stability Justify Buy Rating
Premium
Ratings
MacroGenics: Strategic Pipeline Shifts and Financial Stability Justify Buy Rating
5M ago
MacroGenics price target lowered to $5 from $6 at Stifel
Premium
The Fly
MacroGenics price target lowered to $5 from $6 at Stifel
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100